Education
About Us
Working with TipRanks
Follow Us
Carl Zeiss Meditec (GB:0DHC)
LSE:0DHC
Total Valuation
Carl Zeiss Meditec has a market cap or net worth of €4.81B. The enterprise value is €6.91B.
Market Cap€4.81B
Enterprise Value€6.91B
Share Statistics
Carl Zeiss Meditec has 89,440,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding89,440,570
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
Carl Zeiss Meditec’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 4.63%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)4.63%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee10.00T>
Profits Per Employee10.00T>
Employee Count―
Asset Turnover0.61
Inventory Turnover1.82
Valuation Ratios
The current PE Ratio of Carl Zeiss Meditec is 35.37. Carl Zeiss Meditec’s PEG ratio is -0.93.
PE Ratio35.37
PS Ratio5.60
PB Ratio3.10
Price to Fair Value3.10
Price to FCF66.46
Price to Operating Cash Flow25.56
PEG Ratio-0.93
Income Statement
In the last 12 months, Carl Zeiss Meditec had revenue of 2.07B and earned 178.73M in profits. Earnings per share was 2.01.
Revenue2.07B
Gross Profit1.09B
Operating Income176.35M
Pretax Income240.87M
Net Income178.73M
EBITDA403.06M
Earnings Per Share (EPS)2.01
Cash Flow
In the last 12 months, operating cash flow was 220.02M and capital expenditures -80.15M, giving a free cash flow of -12.34M billion.
Operating Cash Flow220.02M
Free Cash Flow-12.34M
Free Cash Flow per Share-0.14
Dividends & Yields
Carl Zeiss Meditec pays an annual dividend of €0.6, resulting in a dividend yield of 1.02%
Dividend Per Share€0.6
Dividend Yield1.02%
Payout Ratio29.20%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.42
52-Week Price Change-40.76%
50-Day Moving Average58.72
200-Day Moving Average58.11
Relative Strength Index (RSI)51.46
Average Volume (3m)25.08K
Important Dates
Carl Zeiss Meditec upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateFeb 12, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend DateMar 27, 2025
Financial Position
Carl Zeiss Meditec as a current ratio of 2.13, with Debt / Equity ratio of 0.00%
Current Ratio2.13
Quick Ratio1.19
Debt to Market Cap0.00
Net Debt to EBITDA0.33
Interest Coverage Ratio-12.10
Taxes
In the past 12 months, Carl Zeiss Meditec has paid 60.71M in taxes.
Income Tax60.71M
Effective Tax Rate0.25
Enterprise Valuation
Carl Zeiss Meditec EV to EBITDA ratio is 16.01, with an EV/FCF ratio of 67.84.
EV to Sales3.12
EV to EBITDA16.01
EV to Free Cash Flow67.84
EV to Operating Cash Flow26.09
Balance Sheet
Carl Zeiss Meditec has €20.29M in cash and marketable securities with €0.00 in debt, giving a net cash position of -€20.29M billion.
Cash & Marketable Securities€20.29M
Total Debt€0.00
Net Cash-€20.29M
Net Cash Per Share-€0.23
Tangible Book Value Per Share€4.13
Margins
Gross margin is 61.15%, with operating margin of 8.54%, and net profit margin of 8.65%.
Gross Margin61.15%
Operating Margin8.54%
Pretax Margin11.66%
Net Profit Margin8.65%
EBITDA Margin19.51%
EBIT Margin13.08%
Analyst Forecast
The average price target for Carl Zeiss Meditec is €60.75, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target€60.75
Price Target Upside3.70% Upside
Analyst ConsensusHold
Analyst Count10
Revenue Growth Forecast―
EPS Growth Forecast―